Open AccessCancer immunotherapy in patients with new or recurrent malignancies after liver transplantation
Author(s) -
Mengqi Liu,
Wenzhi Guo,
Shuijun Zhang
Publication year - 2017
Publication title -
international journal of surgery. oncology
Language(s) - English
Resource type - Journals
ISSN - 2471-3864
DOI - 10.1097/ij9.0000000000000049
Subject(s) - medicine , radiation oncology , multidisciplinary approach , publication , translational research , oncology , transplantation , clinical oncology , medical education , medical physics , cancer , radiation therapy , pathology , social science , sociology , advertising , business
Cancer immunotherapy, as a new treatment modality, has been shown to be effective, especially in metastatic melanoma and lung cancer. Organ transplantation can be a life-saving procedure for patients with end-stage diseases of lung, heart, kidney and liver. While ironically, as improvements in organ transplantation have extended patients’ lives, new or recurrent postsurgical malignancies have become an increasing threat to their long-term survival, especially in patients after liver transplantation due to hepatocellular carcinoma. The feasibility of immunotherapy treatment for such patients is still to be investigated.